Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01738607 · ClinicalTrials.gov registry record · NA
Dietary Fiber for Fecal Incontinence
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT01738607: Completed NA study, sponsored by University of Minnesota.
NCT01738607 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01738607, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The primary aim of this study was to compare the effects of supplementation with one of three dietary fibers (gum arabic, carboxy-methylcellulose, or psyllium) or a placebo on fecal incontinence (FI), symptom intolerance, and quality of life in community-living individuals who have incontinence of loose or liquid feces. A secondary aim was to explore the possible mechanism(s) underlying the supplements' efficacy (i.e., improvements in stool consistency, water-holding capacity or gel formation).
Primary Outcome
the date and time of an incontinence episode was reported and the ratio of the number of incontinence episodes to total stools daily was calculated
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Psyllium
- DIETARY_SUPPLEMENT Gum Arabic
- DIETARY_SUPPLEMENT carboxymethylcellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2004-04 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT01738607 record still lists
NCT01738607 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01738607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01738607 about?
NCT01738607 is a clinical study titled "Dietary Fiber for Fecal Incontinence". The primary aim of this study was to compare the effects of supplementation with one of three dietary fibers (gum arabic, carboxy-methylcellulose, or psyllium) or a placebo on fecal incontinence (FI), symptom intolerance, and quality of life in community-living individuals who have incontinence of l...
What is the current status of trial NCT01738607?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2004-04. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01738607?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Psyllium (DIETARY_SUPPLEMENT), Gum Arabic (DIETARY_SUPPLEMENT), carboxymethylcellulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01738607?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01738607's enrollment target sits among peer trials
206 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia